DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,288,971 | +2.0% | 9,226 | -1.3% | 0.06% | -35.4% |
| Q2 2023 | $2,244,000 | +86708.5% | 9,350 | -8.8% | 0.10% | -54.4% |
| Q1 2023 | $2,585 | -5.7% | 10,256 | -0.7% | 0.22% | +7.4% |
| Q4 2022 | $2,742 | -99.9% | 10,330 | -0.9% | 0.20% | +77.2% |
| Q3 2022 | $2,693,000 | -9.2% | 10,425 | -10.9% | 0.11% | +37.3% |
| Q2 2022 | $2,966,000 | -11.8% | 11,700 | +2.0% | 0.08% | 0.0% |
| Q1 2022 | $3,364,000 | -12.2% | 11,469 | -1.5% | 0.08% | -8.8% |
| Q4 2021 | $3,832,000 | +4.6% | 11,646 | -3.3% | 0.09% | -7.1% |
| Q3 2021 | $3,665,000 | -27.1% | 12,039 | -35.7% | 0.10% | -38.8% |
| Q2 2021 | $5,027,000 | -4.4% | 18,731 | -19.8% | 0.16% | -24.5% |
| Q1 2021 | $5,258,000 | -7.4% | 23,359 | -8.6% | 0.21% | -11.7% |
| Q4 2020 | $5,678,000 | -6.4% | 25,559 | -9.3% | 0.24% | -14.9% |
| Q3 2020 | $6,068,000 | +14.2% | 28,182 | -6.2% | 0.28% | -1.1% |
| Q2 2020 | $5,314,000 | +18.7% | 30,051 | -7.1% | 0.28% | -10.4% |
| Q1 2020 | $4,475,000 | -2.9% | 32,335 | +7.6% | 0.32% | -39.1% |
| Q4 2019 | $4,611,000 | +8.0% | 30,045 | +1.6% | 0.52% | -6.1% |
| Q3 2019 | $4,271,000 | -7.8% | 29,568 | -8.8% | 0.56% | +1.6% |
| Q2 2019 | $4,634,000 | +12.5% | 32,423 | +3.9% | 0.55% | -1.3% |
| Q1 2019 | $4,120,000 | +15.8% | 31,206 | -9.6% | 0.55% | +12.4% |
| Q4 2018 | $3,559,000 | -9.0% | 34,517 | -4.1% | 0.49% | +4.9% |
| Q3 2018 | $3,912,000 | +1.5% | 36,002 | -7.8% | 0.47% | -0.6% |
| Q2 2018 | $3,855,000 | +8.3% | 39,066 | +7.5% | 0.47% | +0.4% |
| Q1 2018 | $3,560,000 | +1.0% | 36,356 | -4.3% | 0.47% | +6.6% |
| Q4 2017 | $3,525,000 | +0.1% | 37,977 | -7.5% | 0.44% | -1.6% |
| Q3 2017 | $3,522,000 | -0.8% | 41,060 | -2.4% | 0.45% | -3.0% |
| Q2 2017 | $3,552,000 | +38.9% | 42,085 | +40.7% | 0.46% | +27.9% |
| Q1 2017 | $2,558,000 | +3.5% | 29,903 | -5.9% | 0.36% | +2.8% |
| Q4 2016 | $2,472,000 | +26.8% | 31,763 | +27.8% | 0.35% | +21.8% |
| Q3 2016 | $1,949,000 | -30.7% | 24,862 | -10.7% | 0.29% | -24.9% |
| Q2 2016 | $2,812,000 | +2.9% | 27,846 | -3.4% | 0.38% | +8.1% |
| Q1 2016 | $2,734,000 | -0.9% | 28,826 | -2.9% | 0.36% | +2.3% |
| Q4 2015 | $2,758,000 | +6.1% | 29,699 | -2.7% | 0.35% | +0.9% |
| Q3 2015 | $2,600,000 | -2.5% | 30,509 | -2.1% | 0.34% | +6.2% |
| Q2 2015 | $2,668,000 | -10.3% | 31,173 | -11.0% | 0.32% | -0.9% |
| Q1 2015 | $2,974,000 | -10.4% | 35,031 | -9.6% | 0.33% | -0.3% |
| Q4 2014 | $3,320,000 | +6.9% | 38,738 | -5.2% | 0.33% | +8.2% |
| Q3 2014 | $3,106,000 | -6.1% | 40,883 | -2.7% | 0.30% | -3.8% |
| Q2 2014 | $3,307,000 | -12.3% | 42,000 | -16.4% | 0.32% | -13.7% |
| Q1 2014 | $3,770,000 | -13.3% | 50,267 | -10.7% | 0.37% | -6.4% |
| Q4 2013 | $4,348,000 | -7.0% | 56,321 | -16.5% | 0.39% | -10.3% |
| Q3 2013 | $4,677,000 | – | 67,476 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |